計畫


第 1 到 14 筆結果，共 14 筆。

啟始時間標題P-Investigator經費來源
2021新冠肺炎智慧醫療平台建立-利用影像偵測身體徵象(1/3)TUNG-HUNG SUNational Science and Technology Council
2021慢性B型肝炎與肝癌之新穎免疫治療－Akt訊息傳遞對反轉T細胞耗竭與組織常駐記憶型T細胞之分化的影響, 及於肝細胞癌之細胞療法的應用(2/5)TUNG-HUNG SUNational Science and Technology Council
2020慢性B型肝炎與肝癌之新穎免疫治療－Akt訊息傳遞對反轉T細胞耗竭與組織常駐記憶型T細胞之分化的影響, 及於肝細胞癌之細胞療法的應用(1/5)TUNG-HUNG SUNational Science and Technology Council
2020Clinical Implications of Nk Cell Receptor Ligands in Hepatocellular Carcinoma Tumor MicroenvironmentTUNG-HUNG SUNational Science and Technology Council
2019The Clinical Immunology Study for Virological Relapse after Discontinuation of Anti-Hbv Therapy( II )TUNG-HUNG SUNational Science and Technology Council
2018The Clinical Immunology Study for Virological Relapse after Discontinuation of Anti-Hbv Therapy(I)TUNG-HUNG SUNational Science and Technology Council
2018The Role of Stat3 Pathway in Liver Fibrogenesis and Antifibrotic Therapy – from Bench Work to Clinical ApplicationTUNG-HUNG SUNational Science and Technology Council
2017The best timing of anti-viral therapy and long-term prognosis in patients with liver fibrosisTUNG-HUNG SUNational Health Research Institutes
2016The Role of Stat3 Pathway in Liver Fibrogenesis and Antifibrotic Therapy – from Bench Work to Clinical ApplicationTUNG-HUNG SUNational Science and Technology Council
2016The best timing of anti-viral therapy and long-term prognosis in patients with liver fibrosisTUNG-HUNG SUNational Health Research Institutes
2015The Study of Viral and Host Factors Associated with Virological Relapse after Discontinuation of Anti-HBV TherapyTUNG-HUNG SUNational Science and Technology Council
2015The best timing of anti-viral therapy and long-term prognosis in patients with liver fibrosisTUNG-HUNG SUNational Health Research Institutes
2014The best timing of anti-viral therapy and long-term prognosis in patients with liver fibrosisTUNG-HUNG SUNational Health Research Institutes
2013The Study of Viral and Host Factors Associated with Virological Relapse after Discontinuation of Anti-HBV TherapyTUNG-HUNG SUNational Science and Technology Council